Cost of primary bloodstream infection and dimensions of impact: a scoping review
DOI:
https://doi.org/10.36517/2175-6783.20262796479Keywords:
Patients; Catheter-Related Infections; Hospital Costs; Hospital Infection Control Program; Patient Safety.Abstract
Objective: to map the costs and dimensions associated with the treatment of bloodstream infection in adult and pediatric patients. Methods: a scoping review conducted across five national and international databases and three gray literature databases. Results: of the 258 studies identified, 12 were included in the final sample. Costs associated with the treatment of bloodstream infections ranged from US$122.91 to US$439,015.00, with increased hospital stays ranging from 10 to 135 days. Qualitative analysis revealed increased morbidity and complications related to prolonged hospitalization, the need to implement interventions to mitigate risks, and the substantial financial burden imposed on healthcare systems. Conclusion: bloodstream infection constitutes an adverse event with significant clinical, economic, and organizational impact, as it is associated with prolonged hospitalization, increased morbidity and mortality, and greater demand for resources, thereby imposing a considerable burden on healthcare systems. Contributions to practice: the findings reinforce the importance of institutional policies focused on patient safety, as well as the adoption of preventive practices aimed at strengthening care outcomes and optimizing available resources.
Downloads
References
1. Acosta NC, Ceratti RN, Santos MS, Fantin SS, Fuzinatto F, Almeida Neto OP, et al. Central line-associated bloodstream infections in patients with COVID-19. Rev Latino-Am Enfermagem. 2024;32:e4236. doi: https://doi.org/10.1590/1518-8345.7007.4236
2. Elangovan S, Lo JJ, Xie Y, Mitchell B, Graves N, Cai Y. Impact of central-line-associated bloodstream infections and catheter-related bloodstream infections: a systematic review and meta-analysis. J Hosp Infect. 2024;152:126-37. doi: https://doi.org/10.1016/j.jhin.2024.08.002
3. Allel K, Stone J, Undurraga EA, Day L, Moore CE, Lin L, et al. The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med. 2023;20(6):e1004199. doi: https://dx.doi.org/10.1371/journal.pmed.1004199
4. Agência Nacional de Vigilância Sanitária (BR). Medidas de prevenção de infecção relacionada à assistência à saúde: série segurança do paciente e qualidade dos serviços de saúde [Internet]. 2017 [cited Feb 2, 2026]. Available from: https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/servicosdesaude/publicacoes/caderno-4-medidas-de-prevencao-de-infeccao-relacionada-a-assistencia-a-saude.pdf
5. Leoncio JM, Almeida VF, Ferrari RAP, Capobiango JD, Kerbauv G, Tacla MTGM. Impact of healthcare-associated infections on the hospitalization costs of children. Rev Esc Enferm USP. 2019;53:e03486. doi: https://doi.org/10.1590/S1980-220X2018016303486
6. Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Scoping reviews. In: Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z. JBI manual for evidence synthesis. Adelaide: JBI; 2024. doi: https://doi.org/10.46658/JBIMES-24-09
7. Pollock D, Peters MDJ, Khalil H, McInerney P, Alexander L, Tricco AC, et al. Recommendations for the extraction, analysis, and presentation of results in scoping reviews. JBI Evid Synth. 2023;21(3):520-32. doi: http://doi.org/10.11124/JBIES-22-00123
8. Haughey BS, White SC, Seckeler M. Catheter-associated bloodstream infection incidence and outcomes in congenital cardiac surgery. Congenit Heart Dis. 2019;14(5):811-3. doi: https://doi.org/10.1111/chd.12809
9. Karagiannidou S, Zaoutis T, Maniadakis N, Papaevangelou V, Kourlaba G. Attributable length of stay and cost for pediatric and neonatal central line-associated bloodstream infections in Greece. J Infect Public Health. 2019;12(3):372-9. doi: https://doi.org/10.1016/j.jiph.2018.12.004
10. Len EK, Akkisetty R, Royal S, Brooks M, Coyle S, Gupta R, et al. Increased healthcare-associated infections in a surgical intensive care unit related to boarding non-surgical patients. Surg Infect (Larchmt). 2019;20(4):332-7. doi: https://dx.doi.org/10.1089/sur.2018.240
11. Baier C, Linke L, Eder M, Schwab F, Chaberny IF, Vonberg RP, et al. Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients. PLoS One. 2020;15(1):e0227772. doi: https://doi.org/10.1371/journal.pone.0227772
12. Brown R, Burke D. The hidden cost of catheter related blood stream infections in patients on parenteral nutrition. Clin Nutr ESPEN. 2020;36:146-9. doi: https://doi.org/10.1016/j.clnesp.2020.01.001
13. Osme SF, Almeida APS, Lemes MF, Barbosa WO, Arantes A, Mendes CM, et al. Costs of healthcare-associated infections to the Brazilian public Unified Health System in a tertiary-care teaching hospital: a matched case-control study. J Hosp Infect. 2020;106(2):303-10. doi: https://dx.doi.org/10.1016/j.jhin.2020.07.015
14. Osme SF, Souza JM, Osme IT, Almeida APS, Mendes-Rodrigues C, Gontijo-Filho PP, et al. Financial impact of healthcare-associated infections on intensive care units estimated for fifty Brazilian university hospitals affiliated to the unified health system. J Hosp Infect. 2021;117:96-102. doi: https://doi.org/10.1016/j.jhin.2021.08.012
15. Khan MO, Uddin NS, Khamisani AM, Shah R. Frequency, causative organisms, excess cost and short-term outcomes of peripheral and central line associated nosocomial blood stream infection in adult patients admitted in a tertiary care hospital. Pak J Med Health Sci. 2023;16(12):521-25. doi: https://doi.org/10.53350/pjmhs20221612521
16. Hou Y, Griffin LP, Ertmer K, Bernatchez SF, Kärpänen TJ, Palka-Santini M. Effectiveness of disinfecting caps for intravenous access points in reducing central line-associated bloodstream infections, clinical utilization, and cost of care during COVID-19. Clinicoecon Outcomes Res. 2023;15:477-86. doi: https://dx.doi.org/10.2147/CEOR.S404823
17. Yu CK, Jung M, Ai C. Characteristics, costs, and outcomes associated with central-line-associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals. Infect Control Hosp Epidemiol. 2023;44(12):1920-6. doi: https://doi.org/10.1017/ice.2023.132
18. Bezerra IL, Nassar AP Jr, Mendonça TS, Tomazini BM, Veiga VC, Arns B, et al. Patient-level cost analysis of intensive care unit-acquired infections: a prospective cohort study. J Hosp Infect. 2024;139:106-14. doi: https://doi.org/10.1016/j.jhin.2024.07.002
19. Yengudhati V, Gutowski J, Glassman S, Phillips M, Frey S, Bronstein M, et al. The differential burden of 3 health care–associated infections on hospital costs and lengths of stay: a quasi-experimental case-control observation. Am J Infect Control. 2024;52(12):1466-8. doi: https://doi.org/10.1016/j.ajic.2024.07.014
20. Centers for Medicare & Medicaid Services (US). Hospital-Acquired Condition Reduction Program [Internet]. 2024 [cited Feb 9, 2026]. Available from: https://www.cms.gov/medicare/quality/value-based-programs/hospital-acquired-conditions
21. Agência Nacional de Vigilância Sanitária (BR). Boletim Segurança do Paciente e Qualidade em Serviços de Saúde nº 32: Avaliação Nacional dos indicadores de IRAS e RM [Internet]. 2024 [cited Feb 9, 2026]. Available from: https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/servicosdesaude/paineis-analiticos/boletins-das-notificacoes-de-iras-e-outros-eventos-adversos
22. Barret D, Noble H. What are cohort studies? Evid Based Nurs. 2019;22(4):95-6. doi: https://doi.org/10.1136/ebnurs-2019-103183
23. Hasan B, Bechenati D, Bethela HM, Cho S, Rajjoub NS, Murad ST, et al. A systematic review of length of stay linked to hospital-acquired falls, pressure ulcers, central line-associated bloodstream infections, and surgical site infections. Mayo Clin Proc Innov Qual Outcomes. 2025;9(3):100607. doi: https://doi.org/10.1016/j.mayocpiqo.2025.100607
24. Pegoraro NB, Miyake AM, Rocha GMS, Boarão GP, Cruz AS, Aladino TML, et al. nfecção primária de corrente sanguínea associada a cateter venoso central em unidade de terapia intensiva neonatal: avaliação da incidência após implantação de pacotes de intervenção (bundle). BioSCI. 2024;82:e00056. doi: https://dx.doi.org/10.55684/2024.82.e00056
25. Cabrero EL, Terradas RR, Cuñado AC, Sardelli DG, López CH, Formatger DG, et al. Risk factors of catheter-associated bloodstream infection: systematic review and meta-analysis. PLoS One. 2023;18(3):e0282290. doi: https://dx.doi.org/10.1371/journal.pone.0282290
26. Rosenthal VD, Memish ZA, Shweta F, Bearman G, Lutwick LI. Preventing central line-associated bloodstream infections: a position paper of the International Society for Infectious Diseases, 2024 update. Int J Infect Dis. 2025;150:107290. doi: https://doi.org/10.1016/j.ijid.2024.107290
27. Alwazzeh MJ, Alnimr A, Al Nassri SA, Alwarthan SM, Alhajri M, Alshehail BM, et al. Microbiological trends and mortality risk factors of central line-associated bloodstream infections in an academic medical center, 2015-2020. Antimicrob Resist Infect Control. 2023;12(1):128. doi: https://doi.org/10.1186/s13756-023-01338-5
28. Devrim I, Özkul MT, Çağlar I, Oruç Y, Demiray N, Tahta N, et al. Central line bundle including split-septum device and single-use prefilled flushing syringes to prevent port-associated bloodstream infections: a cost and resource-utilization analysis. BMC Health Serv Res. 2020;20(1):336. doi: http://doi.org/10.1186/s12913-020-05221-6
29. Carmo Filho R, Carvalho GJ, Santos SM, Rabacow FM, Borges PP. Public policies, hospital management, and local development. GeSec. 2024;15(11):e4328. doi: https://doi.org/10.7769/gesec.v15i11.4328
30. Buetti N, Marschall J, Drees M, Fakih MG, Hadaway L, Maragakis LL, et al. Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol. 2022;43(5):553-69. doi: https://doi.org/10.1017/ice.2022.87
Downloads
Published
Data Availability Statement
The data and content supporting this study are contained within the manuscript itself.
Issue
Section
License
Copyright (c) 2026 Janayna Thais Silva, Daiana Kloh Khalaf, Kariane Gomes Cezario Roscoche, Márcia Helena de Souza Freire, Shirley Boller, Bruna Costa Bueno
This work is licensed under a Creative Commons Attribution 4.0 International License.
